DEVELOPMENT OF A HIGH-THROUGHPUT PROCESS FOR THE PRODUCTION OF DIAGNOSTIC MONOCLONAL ANTIBODIES (Q2035396)

From EU Knowledge Graph
Revision as of 12:36, 19 March 2020 by DG Regio (talk | contribs) (‎Changed an Item: Label in wikidata changed)
Jump to navigation Jump to search
Project in Italy financed by DG Regio
Language Label Description Also known as
English
DEVELOPMENT OF A HIGH-THROUGHPUT PROCESS FOR THE PRODUCTION OF DIAGNOSTIC MONOCLONAL ANTIBODIES
Project in Italy financed by DG Regio

    Statements

    country
    Italy
    0 references
    EU contribution
    5,714.0 Euro
    0 references
    budget
    11,428.0 Euro
    0 references
    co-financing rate
    50.0 percent
    0 references
    start time
    15 November 2016
    0 references
    end time
    7 December 2018
    0 references
    expected end time
    3 December 2018
    0 references
    beneficiary name (string)
    TAKIS SRL
    0 references
    beneficiary
    Q277533
    0 references
    coordinate location

    41°53'35.95"N, 12°28'58.55"E
    0 references
    summary
    L'AZIENDA DI BIOTECNOLOGIE TAKIS PRODUCE IN MODO INNOVATIVO ED EFFICACE ANTICORPI MONOCLONALI PER CONTO PROPRIO E PER CONTO TERZI. SEBBENE MOLTO COMPETITIVA NEI PROTOCOLLI DI VACCINAZIONE, IL PROCESSO ATTUALE MANCA DI UN SISTEMA ROBOTIZZATO PER L (Italian)
    0 references

    Identifiers

    Italian Unique Project Code
    F83G17000640007
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2035396&oldid=2378391"